CXCL9 and neoplasm: However, with tumour progression, changes in the pulmonary immune microenvironment led to dysregulation of symbiotic bacteria, which prevented immune cell migration to lung tissues by inhibiting the CXCL9-CXCR3 axis, promoting tumour occurrence and development.